EPA Subpart P Explained

Subpart P — formally the Management Standards for Hazardous Waste Pharmaceuticals at 40 CFR part 266 — is the EPA rule finalized in 2019 that created a dedicated framework for how healthcare manages hazardous waste pharmaceuticals (HWPs). Before it, facilities squeezed drug waste into the general RCRA generator rules written for industrial chemicals, which fit poorly. Subpart P replaced that with a tailored standard covering identification, containers, accumulation, and disposal. It works alongside the underlying lists — the P-list, U-list, and characteristic D-codes — which still determine whether a drug is hazardous. Subpart P governs how you then manage it.

It also sits next to, but is separate from, the standards staff often confuse it with. USP 800 is a worker-safety handling standard; DEA rules at 21 CFR 1317 govern the destruction of controlled substances. Subpart P is neither of those — it is the EPA hazardous-waste disposal standard for pharmaceuticals. A drug can be subject to all three at once, and a complete program has to satisfy each on its own terms.

Subpart P applies to two groups:

• Healthcare facilities — broadly defined to include hospitals, pharmacies, clinics, physician and dental offices, long-term care, and similar operations that provide or sell drugs. A healthcare facility that generates HWPs manages its non-creditable hazardous waste pharmaceuticals under Subpart P.
• Reverse distributors — the entities that receive potentially creditable hazardous waste pharmaceuticals to evaluate for manufacturer credit. Subpart P sets specific standards for how reverse distributors accumulate and manage these before the remainder is disposed of.

Very small quantity generators (VSQGs) also have a role: a VSQG healthcare facility can opt to operate under Subpart P for its HWPs. Our RCRA hazardous drug disposal service is built around these two audiences.

The headline provision: Subpart P prohibits sewering hazardous waste pharmaceuticals. You may not dispose of an HWP by flushing it down a drain, toilet, or sink. This ban is absolute and applies to all healthcare facilities and reverse distributors that manage HWPs, regardless of generator size — there is no small-quantity exception.

For decades, drain disposal was common practice for expired and returned drugs. Subpart P ended that for the hazardous ones. (The ban targets hazardous waste pharmaceuticals specifically; how you handle non-hazardous drug waste is governed by other rules and local sewer authority requirements, and drain disposal is widely discouraged there too.) In practice, compliance means every hazardous drug is captured in a container and sent to destruction, never a drain. That single change reshaped daily workflow in many pharmacies, where the sink had been the default for expired liquids and partial doses. The fix is procedural rather than expensive: a labeled container within reach at the point of disposal, and staff who know to use it.

One of the most consequential changes is quiet but important: once a healthcare facility manages its hazardous waste pharmaceuticals under Subpart P, those HWPs no longer count toward its generator-status category. Under the old rules, a facility’s drug waste could push it into small- or large-quantity-generator territory, triggering heavier obligations across all of its hazardous waste.

Under Subpart P, HWP volumes are counted separately, so a facility’s generator status is determined by its other (non-pharmaceutical) hazardous waste. Many facilities find this simplifies their overall RCRA posture — but it does not relax the HWP requirements themselves, including the sewer ban and the container and accumulation standards described in our container requirements guide.

Subpart P divides hazardous waste pharmaceuticals into two buckets, and the distinction drives where the drug goes:

• Potentially creditable HWP — a prescription hazardous waste pharmaceutical that has a reasonable expectation of manufacturer credit. Think unused, undispensed, unexpired-or-recently-expired stock in its original packaging. These can be sent to a reverse distributor to pursue credit.
• Non-creditable HWP — a hazardous waste pharmaceutical with no reasonable expectation of credit: dispensed, partially administered, opened, spilled, residues, compounded items, or investigational drugs. These are managed as waste and sent to a permitted disposal facility for destruction.

Reverse distributors evaluate potentially creditable items for credit, then manage whatever remains as hazardous waste under Subpart P’s reverse-distributor standards. Easy Rx Cycle offers both destruction and reverse distribution, so creditable and non-creditable streams are handled through one partner.

Nicotine is P075, an acutely hazardous P-listed waste, which would ordinarily make discarded nicotine products RCRA-hazardous. Subpart P carved out a practical exception: FDA-approved over-the-counter nicotine-replacement therapies — patches, gums, and lozenges sold OTC — are not regulated as hazardous waste when discarded.

The nuance to hold onto: the exemption is limited to OTC NRT products. Prescription nicotine products and e-liquids / e-cigarette nicotine are not covered and remain P075 hazardous waste. So an OTC nicotine patch can go to regular disposal, while a bottle of prescription nicotine solution cannot. When in doubt, treat nicotine as hazardous and confirm the product’s status.

Practical compliance with Subpart P comes down to a handful of steps:

• Identify your hazardous waste pharmaceuticals by mapping your formulary to the P-list, U-list, and characteristics, and separating creditable from non-creditable.
• Segregate non-creditable HWPs into proper, labeled containers — kept closed, marked “Hazardous Waste,” and dated. Facilities may accumulate on site for up to one year, and state rules can be stricter.
• Never sewer a hazardous waste pharmaceutical.
• Train staff so the right drug reaches the right container, and document that training.
• Notify the EPA of Subpart P activity as required, and dispose to a permitted facility on a hazardous-waste manifest, retaining the paperwork.

None of these steps is individually difficult; the failures regulators cite tend to be the ordinary ones — an open lid, a missing accumulation date, a hazardous drug that reached the wrong container, or an expired product that went down a drain out of old habit. A short written procedure and periodic staff refreshers prevent most of them, and a disposal partner that supplies the containers and paperwork removes the guesswork on the back end.

Easy Rx Cycle is a DEA-registered destruction and reverse-distribution company covering all eight waste streams by mail-back and pickup, returning a Certificate of Destruction and manifest copies with no contract required. Get a quote to build a Subpart P-aligned program.